Cargando…
Stromal score is a promising index in tumor patients’ outcome determination
BACKGROUND: Immune status is widely acknowledged as a valuable marker for predicting cancer prognosis and therapy response. However, there has been a limited understanding of the stromal landscape in cancer. METHODS: By employing ESTIMATE, stromal- and immune-scores were inferred for 6193 tumor samp...
Autores principales: | Xu, Xiaoxian, Xu, Yu, Hu, Wangxiong, Hong, Wenjie, Wang, Yichen, Zhang, Xiaojing, Fan, Xiaoji, Wang, Tingzhang, Lou, Hanmei, Yang, Yanmei, Qian, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687043/ https://www.ncbi.nlm.nih.gov/pubmed/38034609 http://dx.doi.org/10.1016/j.heliyon.2023.e22432 |
Ejemplares similares
-
Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System
por: Xu, Xiaoxian, et al.
Publicado: (2020) -
Association mining of mutated cancer genes in different clinical stages across 11 cancer types
por: Hu, Wangxiong, et al.
Publicado: (2016) -
Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020) -
Mutational Bias and Natural Selection Driving the Synonymous Codon Usage of Single-Exon Genes in Rice (Oryza sativa L.)
por: Hu, Huan, et al.
Publicado: (2023) -
Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I–IIB
por: Zhou, Jiansong, et al.
Publicado: (2018)